#$%^&*AU2018236731A120181018.pdf#####C: Interwovn NRPortbl DCC SXD 17741261 Idocx-20 09 2018 ABSTRACT Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): x0 X N N:VR1 LH NO O OH (I) including stereoisomers and pharmaceutically acceptable salts thereof, wherein R , X, Y , Y2 or L are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
